...
机译:Acute kidney injury in patients treated with immune checkpoint inhibitors
Division of Renal Medicine, Brigham and Women’s Hospital;
University of Vermont Larner College of Medicine;
Division of Nephrology, Massachusetts General HospitalDivision of Nephrology, Department of Internal Medicine, The Ohio State University Medical CenterNephrology Department, Vall d’Hebron University Hospital, Vall d'Hebron Institute of ResearchDepartment of Critical Care & Nephrology, King’s College London, Guy’s and St Thomas’ HospitalDivision of Nephrology & Hypertension, Mayo ClinicDivison of Internal Medicine, Section of Nephrology, University of Texas MD Anderson Cancer CenterDivision of Nephrology, Stanford University School of MedicineRenal Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical CollegeDana-Farber Cancer Institute Survivorship ProgramDivision of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell HealthDivision of Nephrology, Duke University School of MedicineDivision of Nephrology and Hypertension, University Hospital Cleveland Medical CenterDepartment of Microbiology, Immunology and Transplantation, Laboratory of Molecular Immunology (Rega Institute for Medical Research)Division of Nephrology, University Hospitals LeuvenDepartment of Nephrology and Hypertension, Northwestern University Feinberg School of MedicineDivision of Nephrology, University of WashingtonDepartment of Nephrology and Medical Intensive CareDivision of Nephrology, Department of Medicine, University of California San FranciscoInstitute of Clinical Medicine, College of Medicine, National Cheng Kung UniversityDivision of Cardiovascular Medicine, Chi-Mei Medical CenterDepartment of Biotechnology, Southern Taiwan University of Science and TechnologyInstitute of Nephrology and Hypertension, Sheba Medical Center and Sackler School of Medicine, Tel Aviv UniversityKatz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of MedicineDivision of Nephrology, Hypertension, and Renal Transplant, Department of Medicine, University of FloridaDivision of Nephrology, University of Virginia Health SystemService of Nephrology, Department of Medicine, University Hospital of Geneva, GenevaDepartment of Medical Oncology, Assistance Publique - Hopitaux de ParisDivision of Nephrology, University Health Network, University of TorontoDivision of Hematology-Oncology, VAGLAHS, Department of Medicine, David Geffen School of Medicine at University of California-Los Angeles, Los AngelesDivision of Hematology/Oncology and Division of Nephrology, The University of Alabama School of MedicineDivision of Nephrology, Department of Medicine, Icahn School of Medicine at the Mount Sinai HospitalRenal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of PennsylvaniaDepartment of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of GroningenDivision of Medical Oncology, Department of Internal Medicine, The Ohio State UniversityNephrology Department, San Carlos Clinical University HospitalDepartment of Critical Care & Nephrology, Guy’s and St Thomas HospitalDivision of Nephrology, King Chulalongkorn Memorial HospitalSechenov Biomedical Science and Technology Park, Sechenov First Moscow State Medical UniversityDepartment of Oncology, Guy’s & St Thomas HospitalDivision of Epidemiology and Population Health, Stanford UniversityLaboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and MetabolismDepartment of Pneumology, University Hospitals LeuvenRobert H. Lurie Comprehensive Cancer Center, Northwestern UniversityMax Delbrück Center for Molecular Medicine, Helmholtz AssociationDivision of Population Sciences, Medical Oncology, Dana-Farber Cancer InstituteDivision of Oncology, Massachusetts General HospitalNew York Nephrology Vasculitis and Glomerular Center;
immunotherapy; CTLA-4 antigen; programmed cell death 1 receptor;